CTRI Number |
CTRI/2020/04/024851 [Registered on: 24/04/2020] Trial Registered Prospectively |
Last Modified On: |
23/04/2020 |
Post Graduate Thesis |
No |
Type of Trial |
Interventional |
Type of Study
|
Nutraceutical Other (Specify) [Herbal mouthwash containing Nutraceuticals] |
Study Design |
Randomized, Parallel Group, Placebo Controlled Trial |
Public Title of Study
|
Herbal mouth wash to minimise radiation induced mucositis in head and neck cancer patients |
Scientific Title of Study
|
Randomised controlled trial to test the efficacy of herbal mouth wash in managing acute toxicity of radiation in Head & Neck cancer patients |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
DrK Ramadas |
Designation |
Professor and Head ,Department of Radiation Oncology ,Regional Cancer Centre,Thiruvananthapuram |
Affiliation |
Regional Cancer Centre, Thiruvananthapuram |
Address |
Dr.K Ramadas
Professor and Head ,Department of Radiation Oncology ,Regional Cancer Centre,Thiruvananthapuram
Thiruvananthapuram KERALA PIN 695011 India |
Phone |
9447042309 |
Fax |
|
Email |
ramdasrcc@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
DrK Ramadas |
Designation |
Professor and Head ,Department of Radiation Oncology ,Regional Cancer Centre,Thiruvananthapuram |
Affiliation |
Regional Cancer Centre, Thiruvananthapuram |
Address |
Dr.K Ramadas
Professor and Head ,Department of Radiation Oncology ,Regional Cancer Centre,Thiruvananthapuram
KERALA PIN 695011 India |
Phone |
9447042309 |
Fax |
|
Email |
ramdasrcc@gmail.com |
|
Details of Contact Person Public Query
|
Name |
DrK Ramadas |
Designation |
Professor and Head ,Department of Radiation Oncology ,Regional Cancer Centre,Thiruvananthapuram |
Affiliation |
Regional Cancer Centre, Thiruvananthapuram |
Address |
Dr.K Ramadas
Professor and Head ,Department of Radiation Oncology ,Regional Cancer Centre,Thiruvananthapuram
KERALA PIN 695011 India |
Phone |
9447042309 |
Fax |
|
Email |
ramdasrcc@gmail.com |
|
Source of Monetary or Material Support
|
REGIONAL CANCER CENTRE, TRIVANDRUM in collaboration with Rajiv Gandhi Centre For Biotechnology, Thiruvananthapuram and Ceego Labs Pvt Ltd, Chennai |
|
Primary Sponsor
|
Name |
Regional Cancer Centre Trivandrum |
Address |
Regional Cancer Centre, Medical College Campus, Trivandrum, PIN 695011 |
Type of Sponsor |
Research institution and hospital |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
DrK Ramadas |
Regional Cancer Centre,Thiruvananthapuram |
Dr.K Ramadas
Professor and Head Radiation Oncology, Regional Cancer Centre,Thiruvananthapuram Thiruvananthapuram KERALA |
9447042309
ramdasrcc@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Human Ethics Committee,Regional Cancer Centre, Thiruvananthapuram |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: C00-C14||Malignant neoplasms of lip, oral cavity and pharynx, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Comparator Agent |
Soda saline mouth wash |
Two formulations of herbal mouthwash containing 5 plant ingredients-Emblica officinalis (dried fruit), Terminalia chebula (dried fruit), Terminalia bellerica (dried fruit), Azadiracta indica (leaf & Bark), Glycyrrhiza glabra (root) |
Intervention |
Two formulations of herbal mouth wash |
3 Arm trial using 2 formulations of herbal mouthwash containing 5 plant ingredients-Emblica officinalis (dried fruit), Terminalia chebula (dried fruit), Terminalia bellerica (dried fruit), Azadiracta indica (leaf & Bark), Glycyrrhiza glabra (root) and third arm using sodasaline mouthwash( control arm) in patients undergoing radical/adjuvant radiotherapy for oral cancer |
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
70.00 Year(s) |
Gender |
Both |
Details |
Patients with oral cancer undergoing radical / adjuvant radiotherapy with or without surgery will be included. |
|
ExclusionCriteria |
Details |
Patients who require adjuvant chemoradiation will not be included. |
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
An Open list of random numbers |
Blinding/Masking
|
Outcome Assessor Blinded |
Primary Outcome
|
Outcome |
TimePoints |
To find out whether the two forms of mouth wash is useful in minimizing side effects of radiation in patients undergoing radiotherapy for oral cancers in terms of oral hygiene, in minimising oral mucositis and in decreasing the severity of analgesic and antibiotic usage.
|
At baseline, Weekly,
at the end of radiotherapy treatment and 6 weeks after the treatment |
|
Secondary Outcome
|
Outcome |
TimePoints |
degree of xerostomia, intolerance to spicy food and the tumour response. |
6 weeks after the completion of treatment |
|
Target Sample Size
|
Total Sample Size="129" Sample Size from India="43"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Phase 3 |
Date of First Enrollment (India)
|
30/04/2020 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
1. R Kunnambath, D Ravindran, R R Kumar, R.Muwonge, R.M. Pillai. Management of Radiation-Induced Oral Mucositis With a Herbal Mouthwash. Int J Radiat Oncol Biol Phys.2013; 87(Supplement 2): S 143. |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
Brief Summary
|
Randomised controlled trial to
test the efficacy of herbal mouth wash in managing acute toxicity of radiation
in Head & Neck cancer patients
Introduction
Oral mucositis is the major dose limiting side effect for patients with
oral cancer undergoing radiotherapy.
Mucositis can interfere with the
patient’s ability to maintain adequate intake of food and liquids. Severe mucositis can lead to treatment
interruptions or premature termination of therapy resulting in poor tumour
control and survival. All patients
undergoing radiotherapy to oral cavity develop some degree of mucositis
Several agents
have been tried to minimize the severity of oral mucositis. But so far, no method has mentioned has been
found to be effective. Regional Cancer Centre, Trivandrum has done a study
earlier using an ayurvedic mouth wash containing 5 plant ingredients-Emblica
officinalis (dried fruit), Terminalia chebula (dried fruit), Terminalia bellerica
(dried fruit), Azadiracta indica (leaf & Bark), Glycyrrhiza glabra (root) in
patients undergoing radiotherapy for oral cancer1. One hundred and
forty eight patients were randomly assigned to use ayurvedic mouth wash or the
standard practice of soda / saline mouthwash.
The ayurvedic
mouth wash delayed the onset of oral mucositis during radiotherapy. Oral
hygiene was significantly better in patients using ayurvedic mouth wash. Analgesic and antibiotic requirements were also low in
these patients. There was a significant
decrease in the late side effects of radiation to the oral cavity such as dryness
of mouth, intolerance to spicy food in the patients who used ayurvedic mouthwash. Use of this mouth wash did not
affect the response to radiotherapy in these patients.
The major
drawback of this mouth wash was the process of preparation of the mouth wash by
the patient and also the shelf life. In
order to overcome this RCC in collaboration with RGCB and Ceego Labs Pvt Ltd,
Chennai has developed mouth wash using the same ingredients with the same
quantity in two forms; one as a ready to use liquid form and another one in a
powder form which can be dissolved in water and can be used.
Aim
To find out
whether these two forms of mouth wash is useful in minimizing the side effects
of radiation in patients undergoing radiotherapy for Head & Neck Cancers
Methodology
Patients
with oral cancer undergoing radical / adjuvant radiotherapy with or without
surgery will be randomized into 3 arms after getting informed consent. Those who require adjuvant chemoradiation
will not be included. However, induction
chemotherapy is not an exclusion criteria.
One arm will be using the liquid form of mouthwash 5 ml dissolved in 20
ml of water. Second one will be using
mouth wash prepared by dissolving 30 gm of the powder dissolved in 300 ml of
water and the control arm will be using the soda saline mouthwash. All patients will be advised to rinse the
mouth with the mouth wash 4 times daily during the entire course of
radiotherapy treatment.
All these patients will be evaluated
weekly. Mucositis grade will be expressed on a 5-point scale using RTOG / ECOG
scoring system. The intensity of pain,
dryness of mouth, alteration and taste will be scored on a 10 – point scale
using a Visual Analogus Scale (VAS).
The use of analgesics, antibiotics and antifungal and oral hygiene will
be recorded in a structured proforma.
Measurements of Weight (Wt) will be done before and after
radiotherapy. All these patients will be
reviewed 6 weeks following the treatment to evaluate the degree of xerostomia,
intolerance to spicy food and the tumour response.
The sample size
is calculated based on the previous study.
Assuming 80% power, 5% and error sample size required is 43 in each arm
Reference
1. R Kunnambath, D Ravindran, R R
Kumar, R.Muwonge, R.M. Pillai. Management of Radiation-Induced Oral Mucositis
With a Herbal Mouthwash. Int J Radiat Oncol Biol Phys.2013; 87(Supplement 2): S
143.
|